Trial intelligence / Profile preview

UCB Transplant in Hematologic Malignancies

NCT00864227Phase 2Completed

Sponsor
Medical College of Wisconsin
Start
Dec 2008
Primary completion
Apr 2011
Modality
Hematopoietic Stem Cells
Countries
1
01

Overview

A Phase 2 trial of umbilical cord blood in precursor B-cell lymphoblastic leukemia (B-ALL), acute myeloid leukemia (AML), Burkitt lymphoma (BL), B cell lymphoma, follicular lymphoma (FL), sponsored by Medical College of Wisconsin. Started Dec 2008; status: completed.

02

Drugs

umbilical cord blood
03

Conditions

precursor B-cell lymphoblastic leukemia (B-ALL)acute myeloid leukemia (AML)Burkitt lymphoma (BL)B cell lymphomafollicular lymphoma (FL)

Beyond the preview

Go deeper on NCT00864227.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00864227.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call